The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥4,760.67Fair value¥10,204.11Bull¥18,532.20
FairClose
52-week traded range
52W low ¥11,070.0052W high ¥18,905.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading above the consensus fair value
ORGANO CORPORATION closed at ¥12,050.00, 18.1% above the consensus fair value of ¥10,204.11 drawn from 9 valuation models.
Financial DNA score 72/100 — Strong. P/E of 19.5x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥4,760.67
-60.5%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
¥6,570.10
-45.5%
√(22.5 × EPS × BVPS)
EPS=617.74, BVPS=3105.67 · outside Graham range (P/E 19.5, P/B 3.9) — asset-light, treat as a rough floor
P/E Fair Value
¥12,354.80
+2.5%
EPS × 20x (sector P/E)
EPS=617.74, Sector P/E=20x
Peter Lynch (PEG)
¥18,532.20
+53.8%
EPS × Growth% (PEG = 1 is fair)
EPS=617.74, g=30%
EV/EBITDA
¥14,766.95
+22.5%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=39.63B
Dividend Discount (DDM)
¥10,801.62
-10.4%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=200.03, r=10%, g=8%
Book Value (P/B)
¥12,034.47
-0.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=3105.67, ROE=21.5%, g=6%, r=10%
Reverse DCF
¥12,050.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 6.8% | Historical: 32.5%
Margin of Safety
¥5,921.39
-50.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=7895.19, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.